Director/PDMR Shareholding

GlaxoSmithKline PLC 17 April 2007 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 16 April 2007 of an increase in their notional interests in Ordinary Shares at a price of £14.33 per share and Ordinary Share ADRs at a price of $57.07 per ADR following the notional re-investment of the dividend paid to shareholders on 12 April 2007. Ordinary Shares ADRs Dr JP Garnier 4,237.88 Mr J S Heslop 997.00 Mr W C Louv 105.44 Dr M M Slaoui 333.85 Mrs C E Bruck Slaoui 29.07 Mr R M Bondy 1,349.50 Mr J M Clarke 898.83 Mr M Dunoyer 508.25 Dr R G Greig 505.00 Mr D Learmouth 97.62 Mr D J Phelan 777.69 Dr D Pulman 505.00 Mr D M Stout 1,653.12 Mr C Viehbacher 777.69 Mr A P Witty 1,349.50 The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period. This notification relates to transactions notified in accordance with Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b). S M Bicknell Company Secretary 17 April 2007 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100